# 2377: hVIVO Lands Landmark Phase III Trial

Page: https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2377-hvivo-lands-landmark-phase-iii-trial
Text version: https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2377-hvivo-lands-landmark-phase-iii-trial.md
Podcast: [The Vox Markets Podcast](https://stenobird.com/podcast/the-vox-markets-podcast-3914537)
Published: 2026-04-22T08:06:56+00:00
Episode link: https://audioboom.com/posts/8893869
Audio file: https://dts.podtrac.com/redirect.mp3/audioboom.com/posts/8893869.mp3?modified=1776845250&sid=5051662&source=rss
Processing state: not_requested
JSON: https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2377-hvivo-lands-landmark-phase-iii-trial
Duration seconds: 439

## Resource

hVIVO has been selected to run the world’s first pivotal Phase III human challenge trial in whooping cough, marking a major scientific milestone and its largest study to date. The contract strengthens revenue visibility into 2026–27 while underlining the growing importance of human challenge trials in accelerating vaccine approvals globally.

## Actions

- request_transcript: `POST https://stenobird.com/v1/public/podcasts/the-vox-markets-podcast-3914537/episodes/2377-hvivo-lands-landmark-phase-iii-trial/transcription-requests` — Idempotently request low-priority transcript generation for this episode.
- read_markdown: `GET https://stenobird.com/podcast/the-vox-markets-podcast-3914537/2377-hvivo-lands-landmark-phase-iii-trial.md` — Read the agent-friendly Markdown representation of this episode resource.

A page view does not enqueue transcription. Agents should invoke `request_transcript` explicitly when they need this episode processed.

## Transcript

Full transcripts are not published on public pages unless there is a clear rights basis.